Teen To Graduate, Despite Fatal Disease PDF Print E-mail
Wednesday, 09 June 2010 09:07
A rare and life threatening medical disorder has kept a Portsmouth teen out of school and unable to walk for months, but Wednesday night he will walk the stage at his graduation. Wednesday night, families will be filing into the N-Telos pavilion in Portsmouth to celebrate the graduation of Churchland High School's class of 2010, and all they've accomplished over the past four years.

But what one student accomplished over the past four weeks might just leave them in awe. "I feel good that I'm still alive," said Jawuan Trotter, who was diagnosed with Scleroderma. While his Churchland classmates have been busy planning new lives, in January Jawuan Trotter was planning for his death.

"I was thinking of my own will in my head; it was a hard time," he said. It was almost unimaginable for the confident teen, who was voted homecoming prince. "We started to notice his hands became very thick and leather like," said Jawuan's mother Desiree Trotter.

His doctor diagnosed him with Scleroderma.

"We had never heard of it," his mother said. "We didn't know what it was, didn't know how to spell it, but she asked us not to look online, because Scleroderma is often deadly and rarely diagnosed in children.

"I think this may be the first patient we've had on our inpatient rehab unit," said Dr. Jean Shelton. She says Scleroderma is an auto-immune disorder; Jawuan's immune system is essentially attacking his own body. "In his case, [the disease] attacks the brain, the spinal chord, as well as the soft tissues, the hands and the arms and throughout the body," Shelton said.

It got so bad, Jawuan could not stand for more than five seconds.

"When I couldn't go to school anymore it was depressing, very depressing," said Jawuan. He started working with therapists at Children's Hospital of the King's Daughters in April. But come Wednesday, it'ill be worth it. "He's graduating with a 3.38 advanced honors diploma," said Desiree Trotter. "That's awesome."

Source: Wavy.com
 
More articles :

» Biomarker Shows Promise In Scleroderma

A biomarker that can be used to screen patients for has shown promise in a proof of concept study. Researchers from St Vincent’s in Melbourne found (ADMA) levels had an acceptable high specificity and sensitivity for detecting the complication,...

» Blocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease

Tamiko R. Katsumoto, Shelia M. Violette, and Dean SheppardReceived 27 May 2011; Accepted 15 August 2011Interstitial lung disease (ILD) is a commonly encountered complication of systemic sclerosis (SSc) and accounts for a significant proportion of...

» Rituximab Shows Promise in Scleroderma

Rituximab (Rituxan) improved lung function in patients with , a small proof-of-principle study found.At one year, patients randomized to receive rituximab had a median 10.25% increase in forced vital capacity (FVC) compared with baseline, while...

» Top 10 Scleroderma Stories For 2012

For the hundreds of thousands of people around the world, living with Scleroderma can be particularly challenging. As part of the Foundation's ongoing mission, we seek to source and provide useful information, tips, and articles which can help...

» Juvenile Scleroderma Progression Similar To Adult Onset

The pattern and course of disease in patients who develop systemic sclerosis in childhood or adolescence is similar to that in patients who develop the disease as adults, data from Europe has shown.There were 60 patients among 5,000 included in the...

» Scientists and Clinicians Address Diagnosis and Treatment for Autoimmune and Autoinflammatory Diseases

Autoimmune and autoinflammatory diseases are a major health issue. The National Institutes of Health reports that up to 23.5 million Americans are afflicted. The American Autoimmune Related Diseases Association reports the number is closer to 50...

Add comment

Do feel free to leave your comments, as they would add value and knowledge to the community. However, please refrain from making any disparaging, uninformed, or unrelated comments. Thanks :)

Security code
Refresh